Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study

Míreanna Comhchosúla

• Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells
  le: Giagulli, Cinzia, et al.
  Foilsithe: (2011)
• Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17
  le: Caccuri, Francesca, et al.
  Foilsithe: (2016)
• HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2
  le: Caccuri, Francesca, et al.
  Foilsithe: (2012)
• Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS
  le: Bugatti, Antonella, et al.
  Foilsithe: (2013)
• Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance
  le: Fogli, Manuela, et al.
  Foilsithe: (2012)